Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Medin

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Roscoe Owen Brady: Passion for patientsJeffrey A Medin
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2025
Tissue accessibility and thresholds in gene therapy for a lysosomal storage disorderJeffrey A Medin
Journal of Cardiology|February 3, 2007
Lentiviral vectors for gene therapy of heart diseaseKoji Higuchi, Jeffrey A Medin
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Engineered Thymidine-Active Deoxycytidine Kinase for Bystander Killing of Malignant CellsAnton Neschadim, Jeffrey A Medin
Expert Review of Vaccines|December 22, 2006
Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trialsMiriam E Mossoba, Jeffrey A Medin
Journal of Cellular Biochemistry. Supplement|June 6, 2002
Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issuesJeffrey A Medin, Daniel H Fowler
World Journal of Stem Cells|January 12, 2018
Yin and Yang of mesenchymal stem cells and aplastic anemiaLarisa Broglie, David Margolis, Jeffrey A Medin
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2007
Anti-CD25 targeted killing of bicistronically transduced cells: a novel safety mechanism against retroviral genotoxicityShobha Ramsubir, Makoto Yoshimitsu, Jeffrey A Medin
Expert Opinion on Biological Therapy|June 7, 2017
Practical considerations for chimeric antigen receptor design and deliveryRobyn A A Oldham, Jeffrey A Medin
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2016
Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity ConcernsDiana Resetca, Anton Neschadim, Jeffrey A Medin
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Roscoe Owen Brady: Passion for patientsJeffrey A Medin
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2025
Tissue accessibility and thresholds in gene therapy for a lysosomal storage disorderJeffrey A Medin
Journal of Cardiology|February 3, 2007
Lentiviral vectors for gene therapy of heart diseaseKoji Higuchi, Jeffrey A Medin
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Engineered Thymidine-Active Deoxycytidine Kinase for Bystander Killing of Malignant CellsAnton Neschadim, Jeffrey A Medin
Expert Review of Vaccines|December 22, 2006
Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trialsMiriam E Mossoba, Jeffrey A Medin
Journal of Cellular Biochemistry. Supplement|June 6, 2002
Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issuesJeffrey A Medin, Daniel H Fowler
World Journal of Stem Cells|January 12, 2018
Yin and Yang of mesenchymal stem cells and aplastic anemiaLarisa Broglie, David Margolis, Jeffrey A Medin
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2007
Anti-CD25 targeted killing of bicistronically transduced cells: a novel safety mechanism against retroviral genotoxicityShobha Ramsubir, Makoto Yoshimitsu, Jeffrey A Medin
Expert Opinion on Biological Therapy|June 7, 2017
Practical considerations for chimeric antigen receptor design and deliveryRobyn A A Oldham, Jeffrey A Medin
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2016
Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity ConcernsDiana Resetca, Anton Neschadim, Jeffrey A Medin
Pageof 13